Published in Pharmacotherapy on June 01, 2009
Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69
Addiction and cognition. Addict Sci Clin Pract (2010) 1.71
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry (2010) 1.51
Projection-specific neuromodulation of medial prefrontal cortex neurons. J Neurosci (2010) 1.50
Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump. Proc Natl Acad Sci U S A (2011) 1.08
Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav (2012) 1.06
Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets (2010) 0.98
Early methylphenidate exposure enhances cocaine self-administration but not cocaine-induced conditioned place preference in young adult rats. Psychopharmacology (Berl) (2010) 0.96
Prescription use disorders in older adults. Am J Addict (2010) 0.93
Psychostimulant addiction treatment. Neuropharmacology (2014) 0.91
Chronic exposure to methylphenidate impairs appendicular bone quality in young rats. Bone (2012) 0.89
One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder. Eur J Clin Pharmacol (2011) 0.88
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. J Pediatr Pharmacol Ther (2016) 0.86
Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. Behav Brain Funct (2012) 0.86
Hippocampus specific iron deficiency alters competition and cooperation between developing memory systems. J Neurodev Disord (2010) 0.86
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder. Systematic review of review papers 2009-2011. An update for clinicians. J Cent Nerv Syst Dis (2011) 0.86
Characterizing heterogeneity in children with and without ADHD based on reward system connectivity. Dev Cogn Neurosci (2015) 0.86
Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol (2011) 0.85
Transdermal and oral dl-methylphenidate-ethanol interactions in C57BL/6J mice: transesterification to ethylphenidate and elevation of d-methylphenidate concentrations. J Pharm Sci (2011) 0.84
Astrocyte-specific disruption of SynCAM1 signaling results in ADHD-like behavioral manifestations. PLoS One (2012) 0.84
Short cognitive behavioral therapy and cognitive training for adults with ADHD - a randomized controlled pilot study. Neuropsychiatr Dis Treat (2010) 0.84
Attention deficit/hyperactivity disorder in adults with sleep apnea. J Clin Psychol Med Settings (2013) 0.82
Accessible online neuroplasticity-targeted training for children with ADHD. Child Adolesc Psychiatry Ment Health (2013) 0.82
Premarket safety and efficacy studies for ADHD medications in children. PLoS One (2014) 0.81
Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial. Child Psychiatry Hum Dev (2011) 0.81
Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats. Psychopharmacology (Berl) (2013) 0.79
Abnormal distracter processing in adults with attention-deficit-hyperactivity disorder. PLoS One (2012) 0.79
Addiction as a systems failure: focus on adolescence and smoking. J Am Acad Child Adolesc Psychiatry (2011) 0.79
Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. PLoS One (2012) 0.78
Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD). PLoS One (2014) 0.78
Prevalence and clinical significance of night eating syndrome in university students. J Adolesc Health (2014) 0.78
Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourse. J Neurochem (2014) 0.78
Drug therapy of attention deficit hyperactivity disorder: current trends. Mens Sana Monogr (2012) 0.78
Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. J Cent Nerv Syst Dis (2012) 0.77
Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment. Curr Psychiatry Rep (2012) 0.77
Memantine versus Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial. Iran J Psychiatry (2015) 0.76
First treatment contact for ADHD: predictors of and gender differences in treatment seeking. Psychiatr Serv (2014) 0.76
Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine. Behav Brain Res (2010) 0.76
Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin ® LA) in school children under daily practice conditions. Atten Defic Hyperact Disord (2014) 0.76
Differences in Speech Recognition Between Children with Attention Deficits and Typically Developed Children Disappear When Exposed to 65 dB of Auditory Noise. Front Psychol (2016) 0.76
Comparing Auditory Noise Treatment with Stimulant Medication on Cognitive Task Performance in Children with Attention Deficit Hyperactivity Disorder: Results from a Pilot Study. Front Psychol (2016) 0.75
Personalized Medication Response Prediction for Attention-Deficit Hyperactivity Disorder: Learning in the Model Space vs. Learning in the Data Space. Front Physiol (2017) 0.75
Training sensory signal-to-noise resolution in children with ADHD in a global mental health setting. Transl Psychiatry (2016) 0.75
Diagnosing and managing violence. Prim Care Companion CNS Disord (2011) 0.75
The impact of pre-injury controlled substance use on clinical outcomes after trauma. J Trauma Acute Care Surg (2016) 0.75
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatr Dis Treat (2017) 0.75
D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task. Psychopharmacology (Berl) (2015) 0.75
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. Am J Psychiatry (2009) 1.82
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry (2007) 1.78
Abnormal brain activity related to performance monitoring and error detection in children with ADHD. Cortex (2005) 1.46
Pharmacological management of treatment-induced insomnia in ADHD. J Am Acad Child Adolesc Psychiatry (2005) 1.44
Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2013) 1.44
Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacol Biochem Behav (2011) 1.37
A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naïve children with attention-deficit/hyperactivity disorder combined type. Biol Psychiatry (2009) 1.11
Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics (2010) 0.99
Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett (2005) 0.94
Neuroanatomical and neuropsychological correlates of the cerebellum in children with attention-deficit/hyperactivity disorder--combined type. J Am Acad Child Adolesc Psychiatry (2011) 0.92
Electrophysiological correlates of response inhibition in children and adolescents with ADHD: influence of gender, age, and previous treatment history. Psychophysiology (2007) 0.91
Medial temporal lobe abnormalities in pediatric unipolar depression. Neurosci Lett (2007) 0.90
Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol (2007) 0.89
Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a ¹H magnetic resonance spectroscopy study. J Am Acad Child Adolesc Psychiatry (2010) 0.89
Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study. Psychiatry Res (2010) 0.84
Anterior cingulate cortex and symptom severity in attention-deficit/hyperactivity disorder. J Abnorm Psychol (2013) 0.84
Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J Pediatr (2007) 0.83
Response inhibition and academic abilities in typically developing children with attention-deficit-hyperactivity disorder-combined subtype. Arch Clin Neuropsychol (2010) 0.83
Neuropsychological deficits in adolescents with conduct disorder and comorbid bipolar disorder: a pilot study. Bipolar Disord (2005) 0.83
Evidence for specificity of ERP abnormalities during response inhibition in ADHD children: a comparison with reading disorder children without ADHD. Brain Cogn (2009) 0.82
Assessment of personality dimensions in children and adolescents with bipolar disorder using the Junior Temperament and Character Inventory. J Child Adolesc Psychopharmacol (2009) 0.81
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. J Manag Care Pharm (2012) 0.79
Mood disorders in individuals with distal 18q deletions. Am J Med Genet B Neuropsychiatr Genet (2013) 0.79
The MTA at 8. J Am Acad Child Adolesc Psychiatry (2009) 0.78
Corpus callosum anatomy in chronically treated and stimulant naïve ADHD. J Atten Disord (2010) 0.78
Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder. Am J Manag Care (2014) 0.77
Tracking the development of bipolar disorder in childhood. Am J Psychiatry (2012) 0.75
Neuroimaging studies in bipolar children and adolescents. Int Rev Neurobiol (2004) 0.75